Beam Therapeutics (NASDAQ:BEAM) said it plans to cut approximately 20% of its workforce, or around 100 jobs, as part of a corporate restructuring initiative. As a result of the layoffs, which are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results